Search for other papers by Maria Luisa Garo in
Google Scholar
PubMed
Search for other papers by Désirée Deandreis in
Google Scholar
PubMed
Search for other papers by Alfredo Campennì in
Google Scholar
PubMed
Search for other papers by Alexis Vrachimis in
Google Scholar
PubMed
Search for other papers by Petra Petranovic Ovcaricek in
Google Scholar
PubMed
Clinic for Nuclear Medicine, University Hospital of Zürich, Zürich, Switzerland
Search for other papers by Luca Giovanella in
Google Scholar
PubMed
database (CRD42022327028). The components of the PICOT questions were: population, patients with papillary thyroid cancer; comparator prognostic factor, single-arm studies; outcomes, OS, DFS, cancer-specific survival, recurrence, CLNM, or LLNM; timing
Search for other papers by Abdul K Siraj in
Google Scholar
PubMed
Search for other papers by Rong Bu in
Google Scholar
PubMed
Search for other papers by Maham Arshad in
Google Scholar
PubMed
Search for other papers by Kaleem Iqbal in
Google Scholar
PubMed
Search for other papers by Sandeep Kumar Parvathareddy in
Google Scholar
PubMed
Search for other papers by Tariq Masoodi in
Google Scholar
PubMed
Search for other papers by Laila Omar Ghazwani in
Google Scholar
PubMed
Search for other papers by Saif S Al-Sobhi in
Google Scholar
PubMed
Search for other papers by Fouad Al-Dayel in
Google Scholar
PubMed
Search for other papers by Khawla S Al-Kuraya in
Google Scholar
PubMed
cancer, among females in Saudi Arabia, with a significantly higher incidence rate when compared to other countries, such as the USA ( 2 , 3 ). Amongst the different subtypes, papillary thyroid cancer (PTC) is the most common and accounts for 80–90% of
Search for other papers by Yuting Shao in
Google Scholar
PubMed
Search for other papers by Xiaole Hu in
Google Scholar
PubMed
Search for other papers by Yuxi Wang in
Google Scholar
PubMed
Search for other papers by Yi Shao in
Google Scholar
PubMed
Search for other papers by Luchuan Li in
Google Scholar
PubMed
Search for other papers by Qingdong Zeng in
Google Scholar
PubMed
Search for other papers by Hong Lai in
Google Scholar
PubMed
Search for other papers by Lei Sheng in
Google Scholar
PubMed
associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer . Thyroid 2014 24 1618 – 1624 . ( https://doi.org/10.1089/thy.2014.0090 ) 16 Demircioglu ZG Aygun N Demircioglu MK Ozguven BY & Uludag M
Search for other papers by Weiwei Liang in
Google Scholar
PubMed
Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China
Search for other papers by Yilin Zhang in
Google Scholar
PubMed
Search for other papers by Yan Guo in
Google Scholar
PubMed
Search for other papers by Pengyuan Zhang in
Google Scholar
PubMed
Search for other papers by Jiewen Jin in
Google Scholar
PubMed
Search for other papers by Hongyu Guan in
Google Scholar
PubMed
Search for other papers by Yanbing Li in
Google Scholar
PubMed
differentiated and anaplastic thyroid cancer), and medullary thyroid cancer ( 1 ). Papillary thyroid cancer (PTC) is the most common subtype of thyroid cancer, which approximately accounts for more than 80% of all thyroid cancers ( 2 , 3 ). The majority of PTCs
Search for other papers by Yuntao Song in
Google Scholar
PubMed
Search for other papers by Jiaxin Wang in
Google Scholar
PubMed
Search for other papers by Yanli Zhu in
Google Scholar
PubMed
Search for other papers by Guohui Xu in
Google Scholar
PubMed
Search for other papers by Tianxiao Wang in
Google Scholar
PubMed
Search for other papers by Bin Zhang in
Google Scholar
PubMed
Introduction The incidence-based mortality rates of thyroid cancer continued to increase over the past few decades, with papillary thyroid cancer (PTC) being the most common histology ( 1 ). Recurrent or persistent metastasis of the neck lymph
Department of Endocrine Surgery, King College London, King's Health Partners, King's College Hospital, Denmark Hill, London, SE5 9RS, UK
Search for other papers by Mubashir Mulla in
Google Scholar
PubMed
Department of Endocrine Surgery, King College London, King's Health Partners, King's College Hospital, Denmark Hill, London, SE5 9RS, UK
Department of Endocrine Surgery, King College London, King's Health Partners, King's College Hospital, Denmark Hill, London, SE5 9RS, UK
Search for other papers by Klaus-Martin Schulte in
Google Scholar
PubMed
Introduction Papillary thyroid cancer (PTC) is the most common thyroid cancer. Metastases from PTC most commonly involve the cervical lymph nodes (CLNs). The incidence of CLN metastases (CLNM) is reported between 30 and 80% (1, 2) . Some studies
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Wensi Huang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Yuying Deng in
Google Scholar
PubMed
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
fourth most common malignant tumor among women ( 1 ). More than 95% of thyroid cancer cases involve differentiated thyroid cancer (DTC) and up to 90% belong to papillary thyroid cancer (PTC) ( 2 ). The BRAF V600E mutation is the most common genetic
Search for other papers by C Chiapponi in
Google Scholar
PubMed
Search for other papers by H Alakus in
Google Scholar
PubMed
Search for other papers by M Faust in
Google Scholar
PubMed
Search for other papers by A M Schultheis in
Google Scholar
PubMed
Search for other papers by J Rosenbrock in
Google Scholar
PubMed
Search for other papers by M Schmidt in
Google Scholar
PubMed
, alongside with complete tumor resection, low morbidity, and satisfying cosmetic results ( 1 ). The use of prophylactic resection of clinically not involved central lymph nodes for papillary thyroid cancer (PTC), for example, is very controversial ( 2 , 3
Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultad de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Tolima, Colombia
Facultad de Ciencias para la Salud, Universidad de Caldas, Manizales, Caldas, Colombia
Search for other papers by Ana P Estrada-Flórez in
Google Scholar
PubMed
Search for other papers by Mabel E Bohórquez in
Google Scholar
PubMed
Hospital Pablo Tobón Uribe, Medellín, Antioquia, Colombia
Search for other papers by Alejandro Vélez in
Google Scholar
PubMed
Search for other papers by Carlos S Duque in
Google Scholar
PubMed
Search for other papers by Jorge H Donado in
Google Scholar
PubMed
Search for other papers by Gilbert Mateus in
Google Scholar
PubMed
Search for other papers by Cesar Panqueba-Tarazona in
Google Scholar
PubMed
Search for other papers by Guadalupe Polanco-Echeverry in
Google Scholar
PubMed
Search for other papers by Ruta Sahasrabudhe in
Google Scholar
PubMed
Search for other papers by Magdalena Echeverry in
Google Scholar
PubMed
Dinamica IPS, Medellín, Antioquia, Colombia
University of California Davis Comprehensive Cancer Center, Sacramento, California, USA
Fundación de Genética y Genómica, Medellín, Antioquia, Colombia
Search for other papers by Luis G Carvajal-Carmona in
Google Scholar
PubMed
Introduction In the United States and several other countries, the incidence of papillary thyroid cancer (PTC) has significantly increased in recent decades ( 1 ). PTC is now the second most commonly diagnosed malignancy among US Latinas ( 2
Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed
Search for other papers by Paulina Tomczuk-Bobik in
Google Scholar
PubMed
Search for other papers by Anna Beata Popławska-Kita in
Google Scholar
PubMed
Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
Search for other papers by Angelika Buczyńska in
Google Scholar
PubMed
Search for other papers by Piotr Szumowski in
Google Scholar
PubMed
Search for other papers by Łukasz Żukowski in
Google Scholar
PubMed
Search for other papers by Janusz Myśliwiec in
Google Scholar
PubMed
Search for other papers by Monika Zbucka-Krętowska in
Google Scholar
PubMed
Search for other papers by Marcin Adamski in
Google Scholar
PubMed
Clinical Research Centre, Medical University of Bialystok, Białystok, Poland
Search for other papers by Adam Jacek Krętowski in
Google Scholar
PubMed
Introduction One of the most common types of endocrine cancer, especially in young women, is thyroid cancer ( 1 ). More than 90% of all thyroid cancers are differentiated thyroid cancers (DTC), including papillary thyroid cancer (PTC) and